Detail of Survey Responses

1. Should ASBMT provide advice to government agencies and third-party payers on the development of measures of treatment outcomes?

        Yes – 169  (96%)
        No – 3  (2%)
        Don’t know/No Opinion – 4  (2%)
        Skipped this Question – 0

2. Should ASBMT develop a model protocol for the measurement and reporting of comprehensive center-specific treatment outcomes?

        Yes – 154  (89%)
        No – 7  (4%)
        Don’t know/No Opinion – 13  (8%)
        Skipped this Question – 2

3. Although the government may initially require only the measurement and reporting of outcomes for allogeneic transplants, should ASBMT-developed protocol also include autologous transplants?

        Yes – 144  (83%)
        No – 16  (9%)
        Don’t know/No Opinion – 14  (8%)
        Skipped this Question  2

4. The Society’s ad hoc committee has proposed three criteria for the development of treatment treatment outcomes measures – that they be accurate, useful and fairly applied.  These are (a) recognition of diversity of individual programs, (b) quality assurance and improvement, and (c) minimal burden for data collection.  Do you agree with these criteria and this approach?

        Yes – 162  (94%)
        No – 6  (4%)
        Don’t know/No Opinion – 5  (3%)
        Skipped this Question – 3